We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Surgical Screening Tool Uncovers Hidden Sleep Apnea

By HospiMedica staff writers
Posted on 15 May 2008
A quick, cheap, and highly accurate scoring system can identify surgical patients who may have the potentially life-threatening condition of obstructive sleep apnea (OSA).

Researchers at the University of Toronto (Canada) developed the STOP questionnaire, a self-administered screening tool consisting of four simple questions answerable with a yes or no. More...
The questionnaire was given to 2467 patients, 27.5% classified as being at high risk of OSA. For validation, the score from the STOP questionnaire was evaluated versus the apnea-hypopnea index from monitored polysomnography; in all 211 patients underwent polysomnography, 34 for the pilot test and 177 for validation.

The test consists of four questions:

S: Do you snore loudly?
T: Do you often feel tired, fatigued, or sleepy during daytime?
O: Has anyone observed you stop breathing during sleep?
P: Do you have or are you being treated for high blood pressure?

If a patient answers yes to two or more of these questions, then he or she is ranked as being at high risk for OSA. The study results showed that in the validation group, the apnea-hypopnea index was 20 +/- 6. The sensitivities of the STOP questionnaire with apnea-hypopnea index greater than 5, greater than 15, and greater than 30 set as cutoff points were 65.6, 74.3, and 79.5%, respectively. When incorporating body mass index (BMI), age over 50, neck circumference, and male gender (all known risk factors for OSA) into the STOP questionnaire, sensitivities were increased to 83.6, 92.9, and 100% with the same apnea-hypopnea index cutoffs. In a companion study to the STOP questionnaire study, the researchers also validated two other screening tools that have been used previously but not definitively validated for surgical patients: the 11-question Berlin Questionnaire and the American Society of Anesthesiologists (ASA) checklist, which contains 12 checkable items for adults and 14 for children. According to the researchers, the validation of these three studies offers objective, reliable tools for detecting OSA in surgical patients. Both studies were published in the May 2008 issue of Anesthesiology.

"Identifying patients with OSA is the first step in preventing postoperative complications,” said lead author Francis Chung, M.D. "Untreated OSA patients are known to have a higher incidence of difficult intubation, postoperative complications, increased intensive care admissions, and greater duration of hospital stay.”


Related Links:
University of Toronto

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.